<VariationArchive RecordType="classified" VariationID="689476" VariationName="NM_025219.3(DNAJC5):c.370_399dup (p.Cys124_Cys133dup)" VariationType="Duplication" Accession="VCV000689476" Version="2" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2023-08-06" DateCreated="2019-09-13" MostRecentSubmission="2022-09-10">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="677069" VariationID="689476">
      <GeneList>
        <Gene Symbol="DNAJC5" FullName="DnaJ heat shock protein family (Hsp40) member C5" GeneID="80331" HGNC_ID="HGNC:16235" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q13.33</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63895126" stop="63936011" display_start="63895126" display_stop="63936011" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62526454" stop="62567383" display_start="62526454" display_stop="62567383" Strand="+" />
          </Location>
          <OMIM>611203</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_025219.3(DNAJC5):c.370_399dup (p.Cys124_Cys133dup)</Name>
      <CanonicalSPDI>NC_000020.11:63930887:ACTGCTGCTGCTGTCTGTGCTGCTGCTTCAACTGCTGCTGC:ACTGCTGCTGCTGTCTGTGCTGCTGCTTCAACTGCTGCTGCTGTCTGTGCTGCTGCTTCAACTGCTGCTGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>20q13.33</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="63930887" stop="63930888" display_start="63930887" display_stop="63930888" variantLength="30" positionVCF="63930887" referenceAlleleVCF="T" alternateAlleleVCF="TACTGCTGCTGCTGTCTGTGCTGCTGCTTCA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="62562240" stop="62562241" display_start="62562240" display_stop="62562241" variantLength="30" positionVCF="62562240" referenceAlleleVCF="T" alternateAlleleVCF="TACTGCTGCTGCTGTCTGTGCTGCTGCTTCA" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.62562252_62562281dup" Assembly="GRCh37">
            <Expression>NC_000020.10:g.62562252_62562281dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.63930899_63930928dup" Assembly="GRCh38">
            <Expression>NC_000020.11:g.63930899_63930928dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029805.2" sequenceAccession="NG_029805" sequenceVersion="2" change="g.40798_40827dup">
            <Expression>NG_029805.2:g.40798_40827dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_025219.3" sequenceAccession="NM_025219" sequenceVersion="3" change="c.370_399dup" MANESelect="true">
            <Expression>NM_025219.3:c.370_399dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_079495.1" sequenceAccession="NP_079495" sequenceVersion="1" change="p.Cys124_Cys133dup">
            <Expression>NP_079495.1:p.Cys124_Cys133dup</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001821" Type="inframe_insertion" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_831" sequenceAccession="LRG_831">
            <Expression>LRG_831:g.40798_40827dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_831t1" sequenceAccession="LRG_831t1">
            <Expression>LRG_831t1:c.370_399dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_831p1" sequenceAccession="LRG_831p1" change="p.Cys124_Cys133dup">
            <Expression>LRG_831p1:p.Cys124_Cys133dup</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="611203.0003" DB="OMIM" />
        <XRef Type="rs" ID="1600887859" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_025219.3(DNAJC5):c.370_399dup (p.Cys124_Cys133dup) AND Ceroid lipofuscinosis, neuronal, 4 (Kufs type)" Accession="RCV000850191" Version="2">
        <ClassifiedConditionList TraitSetID="7218">
          <ClassifiedCondition DB="MedGen" ID="C1834207">Ceroid lipofuscinosis, neuronal, 4 (Kufs type)</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-09-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-09-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2019-09-13" MostRecentSubmission="2022-09-10">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">31919451</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="7218" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1353" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Kufs disease autosomal dominant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ceroid lipofuscinosis neuronal Parry type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Dominant form of adult neuronal ceroid-lipofuscinosis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neuronal ceroid lipofuscinosis 4B</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ceroid lipofuscinosis neuronal 4B autosomal dominant</ElementValue>
                <XRef ID="Ceroid+Lipofuscinosis+Neuronal+4B+Autosomal+Dominant/1255" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Ceroid lipofuscinosis, neuronal, 4 (Kufs type)</ElementValue>
                <XRef ID="MONDO:0008083" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CLN4</ElementValue>
                <XRef Type="MIM" ID="162350" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1222" />
                <XRef ID="1222" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">DNAJC5-Related Neuronal Ceroid-Lipofuscinosis</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">CLN4 Disease</Attribute>
              </AttributeSet>
              <XRef ID="228343" DB="Orphanet" />
              <XRef ID="79262" DB="Orphanet" />
              <XRef ID="C1834207" DB="MedGen" />
              <XRef ID="MONDO:0008083" DB="MONDO" />
              <XRef Type="MIM" ID="162350" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1945638" SubmissionDate="2019-09-02" DateLastUpdated="2019-09-13" DateCreated="2019-09-13">
        <ClinVarSubmissionID localKey="SUB6205459" submittedAssembly="hg19" title="SUB6205459" />
        <ClinVarAccession Accession="SCV000987304" DateUpdated="2019-09-13" DateCreated="2019-09-13" Type="SCV" Version="1" SubmitterName="Research Unit for Rare Diseases, 1st Faculty of Medicine, Charles University in Prague" OrgID="507113" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.370_399dup (p.(Y120YCCCCLCCCFN)), in exon 4 of DNAJC5 (NM_025219.2) variant has been reported in one canadian family with ausomal dominant adult-onset neuronal ceroid lipofuscinosis.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Ethnicity>Caucasian</Ethnicity>
              <GeographicOrigin>Canada</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">30</Age>
              <Age Type="maximum" age_unit="years">39</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
              <Indication Type="Indication">
                <Trait Type="Finding">
                  <Name>
                    <ElementValue Type="Preferred">Clinical features observed in this individual</ElementValue>
                  </Name>
                </Trait>
              </Indication>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0001250" />
              </Trait>
              <Trait Type="Finding" ClinicalFeaturesAffectedStatus="present">
                <XRef DB="HP" ID="HP:0000726" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DNAJC5">
              <Name>DnaJ heat shock protein family (Hsp40) member C5</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_025219.3:exon 4</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_025219.3:c.370_399dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="162350" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6205459</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5024014" SubmissionDate="2022-09-02" DateLastUpdated="2022-09-10" DateCreated="2022-09-10">
        <ClinVarSubmissionID localKey="611203.0003_CEROID LIPOFUSCINOSIS, NEURONAL, 4 (KUFS TYPE)" title="DNAJC5, 30-BP DUP, NT370_CEROID LIPOFUSCINOSIS, NEURONAL, 4 (KUFS TYPE)" />
        <ClinVarAccession Accession="SCV002569133" DateUpdated="2022-09-10" DateCreated="2022-09-10" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-02">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs with autosomal dominant Kufs disease (CLN4; 162350), Jedlickova et al. (2020) identified a heterozygous 30-bp duplication (c.370_399dup, NM_025219.2) in exon 4 of the DNAJC5 gene, resulting in an in-frame duplication (Cys124_Cys133). The mutation was identified by whole-exome sequencing and confirmed by Sanger sequencing. The duplication encodes the central core motif of the cysteine-string domain of CSP-alpha. Expression of mutant CSP-alpha in CAD5 cells showed abnormal cellular localization with reduced expression in the plasma membrane, abnormal palmitoylation with only the nonpalmitoylated form present, and formation of high molecular weight aggregates.</Attribute>
              <Citation>
                <ID Source="PubMed">31919451</ID>
              </Citation>
              <XRef DB="OMIM" ID="162350" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DNAJC5" />
          </GeneList>
          <Name>DNAJC5, 30-BP DUP, NT370</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">30-BP DUP, NT370</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="611203.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CEROID LIPOFUSCINOSIS, NEURONAL, 4 (KUFS TYPE)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1945638" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001250" MappingRef="HP">
        <MedGen CUI="C0036572" Name="Seizure" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1945638" TraitType="Disease" MappingType="XRef" MappingValue="162350" MappingRef="OMIM">
        <MedGen CUI="C1834207" Name="Ceroid lipofuscinosis, neuronal, 4 (Kufs type)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5024014" TraitType="Disease" MappingType="Name" MappingValue="CEROID LIPOFUSCINOSIS, NEURONAL, 4 (KUFS TYPE)" MappingRef="Preferred">
        <MedGen CUI="C1834207" Name="Ceroid lipofuscinosis, neuronal, 4 (Kufs type)" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1945638" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000726" MappingRef="HP">
        <MedGen CUI="C0497327" Name="Dementia" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

